394 related articles for article (PubMed ID: 20712246)
1. [Health economic impact of viral respiratory infections and pneumonia diseases on the elderly population in Poland].
Jahnz-Rózyk K
Pol Merkur Lekarski; 2010 Jul; 29(169):37-40. PubMed ID: 20712246
[TBL] [Abstract][Full Text] [Related]
2. [Preliminary assessment of Streptococcus pneumoniae, pneumonia, economical and clinical burden in Romania].
Stoicescu IP; Mihăescu T; Azoicăi D; Aramă V; Bâlcu I
Pneumologia; 2007; 56(3):118-23. PubMed ID: 18019971
[TBL] [Abstract][Full Text] [Related]
3. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
[TBL] [Abstract][Full Text] [Related]
4. The cost of influenza in Thailand.
Simmerman JM; Lertiendumrong J; Dowell SF; Uyeki T; Olsen SJ; Chittaganpitch M; Chunsutthiwat S; Tangcharoensathien V
Vaccine; 2006 May; 24(20):4417-26. PubMed ID: 16621187
[TBL] [Abstract][Full Text] [Related]
5. [An economic evaluation of strategy for expanding influenza vaccination in Japan].
Hara Y
Nihon Rinsho; 2003 Nov; 61(11):2013-8. PubMed ID: 14619447
[TBL] [Abstract][Full Text] [Related]
6. [Costs of chronic obstructive pulmonary disease in patients treated in ambulatory care in Poland].
Jahnz-Różyk K; Targowski T; From S; Faluta T; Borowiec L
Pneumonol Alergol Pol; 2011; 79(5):337-42. PubMed ID: 21861257
[TBL] [Abstract][Full Text] [Related]
7. Implementing an influenza vaccination programme for adults aged ≥65 years in Poland: a cost-effectiveness analysis.
Brydak L; Roiz J; Faivre P; Reygrobellet C
Clin Drug Investig; 2012 Feb; 32(2):73-85. PubMed ID: 22201294
[TBL] [Abstract][Full Text] [Related]
8. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community.
Nichol KL; Margolis KL; Wuorenma J; Von Sternberg T
N Engl J Med; 1994 Sep; 331(12):778-84. PubMed ID: 8065407
[TBL] [Abstract][Full Text] [Related]
9. Cost associated with the treatment of influenza in a managed care setting.
Cox F; Khan ZM; Schweinle JE; Okamoto L; McLaughlin T
MedGenMed; 2000 Oct; 2(4):E34. PubMed ID: 11104480
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness analysis of influenza and pneumococcal vaccinations among elderly people in Japan.
Cai L; Uchiyama H; Yanagisawa S; Kamae I
Kobe J Med Sci; 2006; 52(3-4):97-109. PubMed ID: 16855372
[TBL] [Abstract][Full Text] [Related]
11. Modelling the health-economic impact of the next influenza pandemic in The Netherlands.
Hak E; Meijboom MJ; Buskens E
Vaccine; 2006 Nov; 24(44-46):6756-60. PubMed ID: 16797797
[TBL] [Abstract][Full Text] [Related]
12. [Economic cost of Streptococcus pneumoniae community-acquired pneumonia, meningitis and bacteremia in an adult population that required hospitalization in Bogotá, Colombia].
Calderón C; Dennis R
Biomedica; 2014; 34(1):92-101. PubMed ID: 24967862
[TBL] [Abstract][Full Text] [Related]
13. Direct medical cost of influenza-related hospitalizations in children.
Keren R; Zaoutis TE; Saddlemire S; Luan XQ; Coffin SE
Pediatrics; 2006 Nov; 118(5):e1321-7. PubMed ID: 17079533
[TBL] [Abstract][Full Text] [Related]
14. [Costs of exacerbations of chronic obstructive pulmonary disease in primary and secondary care in 2007--results of multicenter Polish study].
Jahnz-Rózyk K; Targowski T; From S
Pol Merkur Lekarski; 2009 Mar; 26(153):208-14. PubMed ID: 19388534
[TBL] [Abstract][Full Text] [Related]
15. Preventing pneumonia: the role for pneumococcal and influenza vaccines.
Shorr AF
Clin Chest Med; 2005 Mar; 26(1):123-34. PubMed ID: 15802174
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of outpatient and inpatient costs of moderate and severe exacerbations of chronic obstructive pulmonary disease in Poland].
Jahnz-Rózyk K; Targowski T; From S
Pneumonol Alergol Pol; 2008; 76(6):426-31. PubMed ID: 19173191
[TBL] [Abstract][Full Text] [Related]
17. The annual impact of seasonal influenza in the US: measuring disease burden and costs.
Molinari NA; Ortega-Sanchez IR; Messonnier ML; Thompson WW; Wortley PM; Weintraub E; Bridges CB
Vaccine; 2007 Jun; 25(27):5086-96. PubMed ID: 17544181
[TBL] [Abstract][Full Text] [Related]
18. Estimating the economic impact of a half-day reduction in length of hospital stay among patients with community-acquired pneumonia in the US.
Raut M; Schein J; Mody S; Grant R; Benson C; Olson W
Curr Med Res Opin; 2009 Sep; 25(9):2151-7. PubMed ID: 19601711
[TBL] [Abstract][Full Text] [Related]
19. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
[TBL] [Abstract][Full Text] [Related]
20. Hospital utilization and costs among children with influenza, 2003.
Hassan F; Lewis TC; Davis MM; Gebremariam A; Dombkowski K
Am J Prev Med; 2009 Apr; 36(4):292-6. PubMed ID: 19201147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
